The Low Voltage Guided Ablation Trail of Persistent Atrial Fibrillation

• Register: ClinicalTrials.gov
• Last refreshed on: 13 June 2016
• Main ID: NCT02732626
• Date of registration: 23/03/2016
• Prospective Registration: Yes
• Primary sponsor: Mödling Hospital
• Public title: The Low Voltage Guided Ablation Trail of Persistent Atrial Fibrillation ERASE-AF
• Scientific title: The Low Voltage Guided Ablation Trail of Persistent Atrial Fibrillation
• Date of first enrolment: April 2016
• Target sample size: 320
• Recruitment status: Recruiting
• URL: https://clinicaltrials.gov/show/NCT02732626
• Study type: Interventional
• Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
• Phase: N/A

Countries of recruitment

Austria, Germany

Contacts

• Name: Christopher Piorkowski, MD
• Affiliation: Heart Center Dresden

• Name: Robert Schönbauer, MD

Key inclusion & exclusion criteria

Inclusion Criteria:

- Symptomatic patients with persistent AF documented by 12 lead ECGs (Persistent AF is
defined as an AF episode which lasts longer than 7 days, Persistent AF which lasted
longer than 12 months will be defined as long standing persistent AF.)

- Age 18 - 80 years, both genders

- Patient is willing to participate in the study (signed written informed consent)

- Patient is willing and available to perform all follow ups.

Exclusion Criteria:

- Atrial fibrillation due to reversible causes

- Any contraindication for AF ablation

- Contraindications to anticoagulation

- CVA/TIA in the past 6 months

- Previous left atrial catheter ablation



Age minimum: 18 Years
Age maximum: 80 Years
Gender: Both

Health Condition(s) or Problem(s) studied

Persistent Atrial Fibrillation

Intervention(s)

Procedure: radiofrequency ablation

Primary Outcome(s)

recurrence of atrial fibrillation [Time Frame: 12 months]

Secondary ID(s)

1.0

Source(s) of Monetary Support

Please refer to primary and secondary sponsors